Molecular Templates Announces Initiation of Phase II Monotherapy Study of MT-3724 in Relapsed/Refractory Diffuse Large B-Cell Lymphoma Patients March 28, 2019 - NASDAQ Companies 0 » View More News for March 28, 2019